FIELD: medicine. SUBSTANCE: method involves additionally administering Myelopid before and after the operation during 3-5 days at a dose of 0.04-0.06 mg/kg of body weight not more than 5 injections. EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING INFLAMMATORY EXUDATIVE POSTOPERATIVE REACTIONS FOLLOWING IMPLANTATION OF INTRAOCULAR LENS | 2008 |
|
RU2381775C1 |
| METHOD OF TREATING POSTTRAUMATIC INTRAOCULAR INFECTION | 1996 |
|
RU2126236C1 |
| METHOD FOR COMPLEX THERAPY OF CORNEAL ULCERS | 2004 |
|
RU2258510C1 |
| METHOD OF PROPHYLAXIS OF CHRONIC POSTTRAUMATIC UVEITIS | 1996 |
|
RU2128031C1 |
| METHOD OF TREATING EXUDATIVE IRIDOCYCLITES DEVELOPED AFTER INTRAOCULAR LENS IMPLANTATION | 2008 |
|
RU2376956C1 |
| METHOD FOR TREATING THE CASES OF POSTOPERATIVE INFLAMMATORY COMPLICATIONS AFTER CATARACT EXTRACTION AND ARTIFICIAL EYE LENS IMPLANTATION | 2005 |
|
RU2290203C1 |
| METHOD FOR TREATING ENDOGENOUS AND POSTOPERATIVE UVEITIS | 1996 |
|
RU2107480C1 |
| METHOD FOR TREATING POSTOPERATIVE UVEITIS CASES | 2006 |
|
RU2307653C1 |
| METHOD FOR TREATING THE CASES OF POST-INFLAMMATION BULLOUS KERATOPATHY | 2000 |
|
RU2165747C1 |
| METHOD OF SURGICAL TREATMENT OF REFRACTORY GLAUCOMA | 2010 |
|
RU2427355C1 |
